Loretta J. Nastoupil, MD, and Marc S. Hoffman, MD, review key updates on the role of CAR T-cell therapy in large B-cell lymphoma (LBCL), follicular lymphoma, and non-Hodgkin’s lymphoma, and discuss how the data applies to clinical practice.
EP. 2: Currently Available Treatment Options for Patients With R/R DLBCLJanuary 23rd 2023
Drs Loretta J. Nastoupil and Marc S Hoffman explain the available treatment options for relapsed/refractory diffuse large B-cell lymphoma and what to consider when selecting a therapy in the second-line setting.
EP. 5: Selecting the Appropriate CAR T-Cell Therapy for Patients with R/R LBCLFebruary 7th 2023
Marc S. Hoffman, MD, explains how to select the appropriate CAR T-cell therapy for each patient, and the barriers patients with R/R LBCL face in receiving CAR T-cell therapy, despite its high efficacy rate.
EP. 8: Utilizing CAR T-Cell Therapy in the Treatment of Relapsed/Refractory Mantle Cell LymphomaFebruary 20th 2023
Wrapping up their discussion, Loretta J. Nastoupil, MD, and Marc S. Hoffman, MD, look at the use of CAR T-cell therapy for patients with mantle cell lymphoma, a rare subtype of non-Hodgkin’s lymphoma.